S-classification of sentinel lymph node biopsy predicts the results of complete regional lymph node dissection

Melanoma Research

Volumn 15, Issue 4, 2005, Pages 267-271

  Fink, Astrid M ^a   Weihsengruber, Felix ^b   Spangl, Bernhard ^c   Feichtinger, Hans ^b   Lilgenau, Nikolaus ^b   Rappersberger, Klemens ^b   Jurecka, Wolfgang ^a   Steiner, Andreas ^a  

^a Wilhelminenspital ^*  (Austria)

^b Krankenhaus Rudolfstiftung   (Austria)

^c UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Malignant melanoma; Regional lymph node dissection; S classification; Sentinel lymph node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 23744447336     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200508000-00006     Document Type: Article

References (33)

1. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early-stage melanoma. Arch Surg 1992; 127:392-399.
2. Morton DL, Chan AD. The concept of sentinel node localization: how it started. Semin Nucl Med 2000; 30:4-10.
3. Reintgen D, Cruse CW, Wells K, Berman C, Fenske N, Glass F, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994; 220:759-767.
4. Thompson JF, McCarthy WH, Bosch CM, O'Brien CJ, Quinn MJ, Paramaesvaran S, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995; 5:255-260.
5. Krag DM, Meijer SJ, Weaver DL, Loggie BW, Harlow SP, Tanabe KK, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995; 130:654-658.
6. Wagner JD, Davidson D, Coleman JJ III, Hutchins G, Schauwecker D, Park HM, et al. Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Ann Surg Oncol 1999; 6:398-404.
7. Joseph E, Brobeil A, Glass F, Glass J, Messina J, DeConti R, et al. Results of complete lymph node dissection in 83 patients with positive sentinel lymph nodes. Ann Surg Oncol 1998; 5:119-125.
8. McMasters KM, Reintgen DS, Ross MI, Gershenwald JE, Edwards MJ, Sober A, et al. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol 2001; 19:2851-2855.
9. Pijpers R, Borgstein PJ, Meijer S, Hoekstra OS, van Hattum LH, Teule GJ. Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg 1997; 21:788-793.
10. Brady MS, Coit DG. Sentinel lymph node evaluation in melanoma. Arch Dermatol 1997; 133:1014-1020.
11. Glass LF, Fenske NA, Messina JL, Cruse CW, Rapaport DP, Berman C, et al. The role of selective lymphadenectomy in the management of patients with malignant melanoma. Dermatol Surg 1995; 21:979-983.
12. Lenisa L, Santinami M, Belli F, Clemente C, Mascheroni L, Patuzzo R, et al. Sentinel node biopsy and selective lymph node dissection in cutaneous melanoma patients. J Exp Clin Cancer Res 1999; 18:69-74.
13. Starz H, Balda BR, Krämer KU, Büchels H, Wang H. A micromorphometry based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001; 91:2110-2121.
14. Wagner JD, Gordon MS, Chuang TY, Chuang TY, Coleman JJ 3rd, Hayes JT, et al. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer 2000; 89:453-462.
15. Wagner JD, Corbett L, Park HM, Davidson D, Coleman JJ, Havlik RJ, et al. Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures. Plast Reconstr Surg 2000; 105:1956-1966.
16. McMasters KM, Wong SL, Edwards MJ, Chao C, Ross MI, Noyes RD, et al. Frequency of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 2002; 9:137-141.
17. Reeves ME, Delgado R, Busam KJ, Brady MS, Coit DG. Prediction of nonsentinel lymph node status in melanoma. Ann Surg Oncol 2003; 10:27-31.
18. Starz H, Siedlecki K, Balda BR. Sentinel lymphonodectomy and S-classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol 2004; 11:162S-168S.
19. Starz H, Cochran AJ, Balda BR. Die Sentinel-Lymphonodektomie aus histopathologischer Sicht. Akt Dermatol 2002; 28:273-278.
20. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19:3635-3648.
21. Ross MI, Balch CM. Surgical treatment of primary melanoma. In: Balch CM, Houghton AN, Sober AJ, Soong SJ (editors): Cutaneous melanoma. St Louis, MO: QMP; 1998, pp. 141-153.
22. Cochran AJ, Starz H. Pathologic aspects. In: Cody HS III (editor): Sentinel lymph node biopsy. London: Martin Dunitz; 2002, pp. 79-90.
23. Cochran AJ, Balda BR, Starz H, Bachter D, Krag DN, Cruse CW, et al. The Augsburger Consensus Techniques of lymphatic mapping, sentinel lymphadenectomy and completion lymphadenectomy in cutaneous malignancies. Cancer 2000; 89:236-241.
24. Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999; 230:453-463.
25. Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng CH, et al. Multiinstitutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I and II melanoma patients. J Clin Oncol 1999; 17:976-983.
26. Buzaid AC, Tinoco LA, Jendiroba D, Tu ZN, Lee JJ, Legha SS, et al. Prognostic value of size of lymph node metastases in patients with cutaneous melanoma. J Clin Oncol 1995; 13:2361-2368.
27. Gershenwald JE, Mansfield PF, Lee JE, Reinigen D. Prognostic significance of sentinel node (SLN) in stage I or II melanoma patients. Melanoma Res 1997; 7(Suppl.):S105.
28. Shivers SC, Wang X, Li W, Joseph E, Messina J, Glass LF, et al. Molecular staging of malignant melanoma: correlation with the clinical outcome. JAMA 1998; 280:1410-1415.
29. Gadd MA, Cosimi AB, Yu J, Duncan LM, Yu L, Flotte TJ, et al. Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg 1999; 134:381-387.
30. McKie RM, Bryne D, Lyngam MK, Sajid M, MacKay AK. Prognostic evaluation of sentinel node biopsy. Melanoma Res 1997; 7:S102.
31. Dewar DJ, Newell B, Green MA, Topping AP, Powell BWEM, Cook MG. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 2004; 22:3345-3349.
32. Scolyer RA, Li LL, McCarthy SW, Shaw HM, Stretch JR, Sharma R, et al. Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. Am J Clin Pathol 2004; 122:532-539.
33. Cochran AJ, Wen DR, Huang RR, Wang HJ, Elashoff R, Morton DL. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcomes based on the primary melanoma and the sentinel node. Mod Pathol 2004; 17:747-755.